A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia

OBJECTIVES: Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting elderly males, often associated with lower urinary tract symptoms (LUTS). α1-blockers are the mainstay in symptomatic therapy of BPH. Because of their greater uroselectivity and minimal hemodynamic effects,...

Descripción completa

Detalles Bibliográficos
Autores principales: Manjunatha, R., Pundarikaksha, H. P., Madhusudhana, H. R., Amarkumar, J., Hanumantharaju, B. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825428/
https://www.ncbi.nlm.nih.gov/pubmed/27127315
http://dx.doi.org/10.4103/0253-7613.178825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825428/
https://www.ncbi.nlm.nih.gov/pubmed/27127315
http://dx.doi.org/10.4103/0253-7613.178825

Ejemplares similares